Tesamorelin - 10mg

Tesamorelin, is a synthetic peptide consisting of 44 amino acids. It is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional, toxic fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction of visceral fat. This peptide has been found to reduce adiposity by nearly 20% in this population. 

Peptide Class:

Growth Hormone-Releasing Hormone (GHRH) Analog

First Developed:

Originally developed in the 1990s as researchers explored improved GHRH analogs with greater stability and longer activity than naturally occurring GHRH.

Primary Research Areas:

Endocrinology • Growth Hormone Regulation • Metabolism • Body Composition • Visceral Adipose Tissue • Healthy Aging

Why Researchers Continue Studying It:

Tesamorelin is one of the best-characterized GHRH analogs available. Its well-understood mechanism of action and extensive publication history continue to make it an important model for studying endocrine signaling and metabolic regulation.

Current Research Focus:

Scientists continue investigating how growth hormone-releasing pathways influence metabolism, insulin sensitivity, body composition, cellular signaling, and age-related physiological changes.